Annovis Bio (ANVS) Prepaid Assets (2019 - 2026)
Annovis Bio (ANVS) posted Prepaid Assets of $89583.0 for Q1 2026, down 72.09% sequentially from $321009.0 in Q4 2025, and down 98.01% YoY from $4.5 million in Q1 2025.
Annovis Bio (ANVS) Prepaid Assets (2019 - 2026) Analysis & Trends
Annovis Bio has reported Prepaid Assets for 8 years, with the latest figure at $89583.0 in Q1 2026.
- Quarterly Prepaid Assets fell 98.01% year-over-year to $89583.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $89583.0 (down 98.01% YoY) and the FY2025 annual result came in at $321009.0, up 1421.51% from the prior year.
- Prepaid Assets eased to $89583.0 in Q1 2026 per ANVS's latest filing, from $321009.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $5.1 million in Q3 2022 and troughed at $21098.0 in Q4 2024.
- A 5-year average of $1.7 million and a median of $202848.0 in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets jumped 11821.9% in 2023, then tumbled 99.53% in 2024.
- Over 5 years, Prepaid Assets stood at $37356.0 in 2022, then surged by 11821.9% to $4.5 million in 2023, then sank by 99.53% to $21098.0 in 2024, then surged by 1421.51% to $321009.0 in 2025, then plunged by 72.09% to $89583.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $89583.0, $321009.0, and $46447.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Annovis Bio | 66.78 Mn | 66.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89,583.00 |
| Dec 31, 2025 | 321,009.00 |
| Sep 30, 2025 | 46,447.00 |
| Jun 30, 2025 | 4.32 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | 21,098.00 |
| Sep 30, 2024 | 189,178.00 |
| Jun 30, 2024 | 202,848.00 |
| Mar 31, 2024 | 188,490.00 |
| Dec 31, 2023 | 4.45 Mn |
| Sep 30, 2023 | 3.87 Mn |
| Jun 30, 2023 | 104,605.00 |
| Mar 31, 2023 | 78,349.00 |
| Dec 31, 2022 | 37,356.00 |
| Sep 30, 2022 | 5.13 Mn |
| Jun 30, 2022 | 3.99 Mn |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 43,736.00 |
| Sep 30, 2021 | 63,790.00 |
| Jun 30, 2021 | 48,283.00 |